NASHVILLE, Tenn.--(BUSINESS WIRE)--Sheridan, the Physician Services Division of AmSurg Corp. (Nasdaq: AMSG), today announced its acquisition of Valley Anesthesiology & Pain Consultants, which will expand its anesthesiology services business and strengthen AmSurg’s presence in Phoenix, Arizona. Valley is one of the largest independent anesthesiology practices in the country, and provides anesthesiology and pain management services through over 240 physicians and 38 allied health providers to 21 hospitals - including nine of the 10 largest hospitals – as well as 25 ambulatory surgery centers and a number of physicians’ offices in the greater Phoenix market.
Aubrey Maze, MD and CEO of Valley commented, “Valley has a long track record of success built upon our providers’ commitment to delivering the best possible care to patients and providing innovative solutions to our hospital and outpatient clients. With AmSurg / Sheridan, we found a partner that is committed to expanding our platform, has an established complementary presence in the Phoenix market and extends the solution set we can offer to our clients. They also embrace a physician-led culture very similar to our own. We believe the combination will enable access to the greater resources now required by our rapidly changing healthcare delivery system and that it will facilitate growth and expanded opportunities for our providers and employees.”
Robert J. Coward, President of Physician Services, added, “We are proud that Valley has chosen Sheridan as its partner. In an increasingly complex and demanding healthcare environment, we believe Sheridan can provide Valley the expertise, resources, and physician-centric culture needed to successfully expand their operations, as well as to continue providing their patients the highest quality of care.”
This press release contains forward-looking statements within the meaning of the federal securities laws, including statements that are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts.
In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” or “predicts,” or the negative of these words or phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters. While forward-looking statements reflect the Company’s good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes. Certain risks and uncertainties related to the Company’s business are or will be described in greater detail in the Company’s filings with the SEC. The information set forth herein should be read in light of such risks.
About AmSurg and Sheridan
AmSurg’s Ambulatory Services Division acquires, develops and operates ambulatory surgery centers in partnership with physicians throughout the U.S. AmSurg’s Physician Services Division, Sheridan, provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities throughout the U.S., primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology. Through these businesses as of September 30, 2015, AmSurg owned and operated 253 ASCs in 34 states and provided physician services to more than 360 healthcare facilities in 27 states. AmSurg has partnerships with, or employs, over 5,000 physicians in 38 states and the District of Columbia.